Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 4 studies | 19% ± 1% | |
| epithelial cell | 4 studies | 28% ± 3% | |
| ciliated cell | 3 studies | 21% ± 4% | |
| GABAergic neuron | 3 studies | 21% ± 4% | |
| glutamatergic neuron | 3 studies | 25% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 4% | |
| basal cell | 3 studies | 25% ± 3% | |
| oligodendrocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1339.02 | 245 / 245 | 100% | 27.21 | 500 / 502 |
| adrenal gland | 100% | 1168.38 | 258 / 258 | 100% | 23.74 | 229 / 230 |
| esophagus | 100% | 896.84 | 1445 / 1445 | 99% | 13.70 | 182 / 183 |
| intestine | 100% | 1053.20 | 966 / 966 | 99% | 16.65 | 524 / 527 |
| lung | 99% | 1015.58 | 575 / 578 | 100% | 17.99 | 1154 / 1155 |
| thymus | 100% | 1510.92 | 653 / 653 | 99% | 26.33 | 601 / 605 |
| stomach | 100% | 926.89 | 359 / 359 | 99% | 15.08 | 284 / 286 |
| breast | 100% | 1224.04 | 459 / 459 | 99% | 21.98 | 1108 / 1118 |
| brain | 99% | 681.57 | 2617 / 2642 | 100% | 24.02 | 704 / 705 |
| bladder | 100% | 974.14 | 21 / 21 | 99% | 16.22 | 498 / 504 |
| ovary | 100% | 1647.99 | 180 / 180 | 99% | 12.34 | 424 / 430 |
| uterus | 100% | 1485.64 | 170 / 170 | 98% | 16.39 | 450 / 459 |
| pancreas | 99% | 590.95 | 326 / 328 | 98% | 16.69 | 175 / 178 |
| kidney | 100% | 553.75 | 89 / 89 | 97% | 14.86 | 877 / 901 |
| liver | 100% | 470.00 | 226 / 226 | 95% | 12.01 | 387 / 406 |
| skin | 100% | 949.64 | 1809 / 1809 | 92% | 13.20 | 432 / 472 |
| adipose | 100% | 954.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 946.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.75 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.22 | 1 / 1 |
| blood vessel | 100% | 1008.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 474.47 | 792 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 11.30 | 28 / 29 |
| heart | 95% | 506.36 | 818 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 81% | 13.07 | 65 / 80 |
| peripheral blood | 66% | 434.45 | 617 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043254 | Biological process | regulation of protein-containing complex assembly |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_1990393 | Cellular component | 3M complex |
| GO_0016020 | Cellular component | membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0050750 | Molecular function | low-density lipoprotein particle receptor binding |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0042826 | Molecular function | histone deacetylase binding |
| Gene name | ANKRA2 |
| Protein name | Ankyrin repeat family A protein 2 (RFXANK-like protein 2) Ankyrin repeat family A member 2 |
| Synonyms | ANKRA |
| Description | FUNCTION: May regulate the interaction between the 3M complex and the histone deacetylases HDAC4 and HDAC5 . May also regulate LRP2/megalin (By similarity). . |
| Accessions | ENST00000504641.1 ENST00000296785.8 Q9H9E1 D6RBK8 |